In conclusion, NFIB promotes CRC growth by increasing intracellular NAD+ levels, which involves the post-transcriptional upregulation of NAMPT via inhibition of miR-182-5p expression (Fig. 7). The gene discussed is NAMPT; the disease is colorectal carcinoma.